Cipla gets final nod from USFDA for multiple sclerosis drug
newsdepo.com
The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc#39;#39;s Tecfidera.Cipla gets final nod from USFDA for multiple sclerosis drug
The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc#39;#39;s Tecfidera. Read more